Nebula Research & Development LLC Natera, Inc. Transaction History

Nebula Research & Development LLC

  • $836 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$85.28 - $112.6 $465,884 - $615,133
5,463 New
5,463 $592 Million
Q3 2023

Nov 14, 2023
BUY
$43.4 - $62.52 $312,827 - $450,644
7,208 Added 91.72%
15,067 $667 Million
Q2 2023

Aug 14, 2023
BUY
$47.08 - $55.16 $370,001 - $433,502
7,859 New
7,859 $382 Million

Others Institutions Holding NTRA

# of Institutions
526
Shares Held
119M
Call Options Held
308K
Put Options Held
191K
View Full List

About Natera, Inc.

NTRA Quotes by TradingView
  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email